Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.
Zhe-Sheng (Jason) Chen Institute for Biotechnology College of Pharmacy and Health Sciences St. John's University New York, NY (USA) Biography
Biography of Zhe-Sheng (Jason) Chen
Dr. Chen obtained a doctorate (Ph.D.) in Pharmacology from the Kagoshima University, Japan. He also holds an MD degree from Guangdong Medical and Pharmaceutical College and a Master's degree in Toxicology from Sun Yat-Sen University, China. Currently, Dr. Chen is a Professor at St. John’s University College of Pharmacy and Health Sciences. He is also a director of the Institute for Biotechnology at St. John’s University. He has published more than 270 scientific publications. Besides, he is the founding Editor in Chief of the Journal of Cancer Research Updates, an Editor-in-Chief of the Journal of New Developments in Chemistry and an editor of the African Journal of Pharmacy and Pharmacology. He is also an editorial board member of 26 journals and a reviewer of more than 240 peer-reviewed journals.